Jonathan Herod

4.1k total citations · 1 hit paper
8 papers, 1.2k citations indexed

About

Jonathan Herod is a scholar working on Oncology, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Jonathan Herod has authored 8 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Reproductive Medicine and 3 papers in Obstetrics and Gynecology. Recurrent topics in Jonathan Herod's work include Ovarian cancer diagnosis and treatment (4 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Cancer Risks and Factors (2 papers). Jonathan Herod is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Cancer Risks and Factors (2 papers). Jonathan Herod collaborates with scholars based in United Kingdom. Jonathan Herod's co-authors include Gordon C. Jayson, Selina Bannoo, David Luesley, M Mascarenhas, Timothy Perren, Stephen Dobbs, Tito Lopes, Sean Kehoe, Sharadah Essapen and Jeremy Twigg and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Gynecologic Oncology.

In The Last Decade

Jonathan Herod

7 papers receiving 1.1k citations

Hit Papers

Primary chemotherapy versus primary surgery for newly dia... 2015 2026 2018 2022 2015 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Herod United Kingdom 7 1.0k 623 576 232 103 8 1.2k
Stephen Dobbs United Kingdom 9 994 1.0× 657 1.1× 557 1.0× 205 0.9× 106 1.0× 16 1.2k
Tito Lopes United Kingdom 5 938 0.9× 615 1.0× 491 0.9× 206 0.9× 96 0.9× 7 1.0k
Enrico Breda Italy 16 730 0.7× 370 0.6× 363 0.6× 273 1.2× 110 1.1× 39 996
Trudy R. Baker United States 18 640 0.6× 316 0.5× 415 0.7× 127 0.5× 126 1.2× 31 881
María Jesús Rubio Spain 16 506 0.5× 344 0.6× 214 0.4× 180 0.8× 69 0.7× 48 693
Howard D. Homesley United States 8 962 1.0× 320 0.5× 1.2k 2.1× 134 0.6× 101 1.0× 9 1.4k
Assumpció Pérez‐Benavente Spain 20 487 0.5× 379 0.6× 685 1.2× 197 0.8× 127 1.2× 73 1.1k
W. Schroeder Germany 11 476 0.5× 294 0.5× 205 0.4× 156 0.7× 68 0.7× 18 651
J A Blessing United States 10 720 0.7× 406 0.7× 735 1.3× 125 0.5× 116 1.1× 18 1.1k
Karin Shih United States 18 561 0.6× 307 0.5× 546 0.9× 204 0.9× 95 0.9× 30 1.0k

Countries citing papers authored by Jonathan Herod

Since Specialization
Citations

This map shows the geographic impact of Jonathan Herod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Herod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Herod more than expected).

Fields of papers citing papers by Jonathan Herod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Herod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Herod. The network helps show where Jonathan Herod may publish in the future.

Co-authorship network of co-authors of Jonathan Herod

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Herod. A scholar is included among the top collaborators of Jonathan Herod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Herod. Jonathan Herod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kehoe, Sean, Jane Hook, Matthew Nankivell, et al.. (2015). Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial. The Lancet. 386(9990). 249–257. 945 indexed citations breakdown →
2.
Kehoe, Sean, Jane Hook, Matthew Nankivell, et al.. (2013). Chemotherapy or upfront surgery for newly diagnosed advanced ovarian cancer: Results from the MRC CHORUS trial.. Journal of Clinical Oncology. 31(15_suppl). 5500–5500. 54 indexed citations
3.
Herod, Jonathan, et al.. (2013). Primary cervical and uterine corpus lymphoma; a case report and literature review.. PubMed. 6(4). 298–306. 22 indexed citations
4.
Barton, Desmond P.J., Raj Naik, & Jonathan Herod. (2009). Efficacy of Systematic Pelvic Lymphadenectomy in Endometrial Cancer (MRC ASTEC Trial). International Journal of Gynecological Cancer. 19(8). 1465–1465. 96 indexed citations
5.
Smith, Gillian, et al.. (2009). Paracentesis in Ovarian Cancer: A Study of the Physiology during Free Drainage of Ascites. Journal of Palliative Medicine. 13(3). 251–254. 8 indexed citations
6.
Herod, Jonathan, et al.. (2007). Infertility after fertility-preserving surgery for cervical carcinoma: the next challenge for reproductive medicine?. Human Fertility. 10(1). 21–24. 14 indexed citations
7.
El‐Ghobashy, Alaa, et al.. (2003). Overexpression of cyclins A and B as markers of neoplastic glandular lesions of the cervix. Gynecologic Oncology. 92(2). 628–634. 17 indexed citations
8.
Herod, Jonathan, et al.. (2001). Hormone replacement therapy following breast and gynaecological cancer. The Obstetrician & Gynaecologist. 3(4). 168–172.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026